CYP2C8 and ovarian cancer: However, analyzing the expression of CYP2C8, 3A4, 3A5, and MDR1 in ovarian cancer following taxane treatment showed no single gene correlation to taxane disposition, but it did connect the ratio of CYP3A5 to MDR1 with DTX clearance (reviewed in [20]).